Literature DB >> 28503016

Comparison of Dichotomized and Distributional Approaches in Rare Event Clinical Trial Design: a Fixed Bayesian Design.

Yang Lei1, Susan Carlson2, Lisa N Yelland3, Maria Makrides4, Robert Gibson5, Byron J Gajewski6.   

Abstract

This research was motivated by our goal to design an efficient clinical trial to compare two doses of docosahexaenoic acid supplementation for reducing the rate of earliest preterm births and/or preterm births. Dichotomizing continuous gestational age data using a classic binomial distribution will result in a loss of information and reduced power. A distributional approach is an improved strategy to retain statistical power from the continuous distribution. However, appropriate distributions that fit the data properly, particularly in the tails, must be chosen, especially when the data are skewed. A recent study proposed a skew-normal method. We propose a three-component normal mixture model and introduce separate treatment effects at different components of gestational age. We evaluate operating characteristics of mixture model, beta-binomial model, and skew-normal model through simulation. We also apply these three methods to data from two completed clinical trials from the USA and Australia. Finite mixture models are shown to have favorable properties in preterm births analysis but minimal benefit for earliest preterm births analysis. Normal models on log transformed data have the largest bias. Therefore we recommend finite mixture model for preterm births study. Either finite mixture model or beta-binomial model is acceptable for earliest preterm births study.

Entities:  

Keywords:  Bayesian; Dichotomization; Normal mixture model; preterm birth; simulation

Year:  2016        PMID: 28503016      PMCID: PMC5423361          DOI: 10.1080/02664763.2016.1214244

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.404


  9 in total

Review 1.  The cost of dichotomising continuous variables.

Authors:  Douglas G Altman; Patrick Royston
Journal:  BMJ       Date:  2006-05-06

2.  Power considerations when a continuous outcome variable is dichotomized.

Authors:  B A Deyi; A S Kosinski; S M Snapinn
Journal:  J Biopharm Stat       Date:  1998-05       Impact factor: 1.051

3.  Dichotomising continuous data while retaining statistical power using a distributional approach.

Authors:  J L Peacock; O Sauzet; S M Ewings; S M Kerry
Journal:  Stat Med       Date:  2012-08-02       Impact factor: 2.373

4.  Joint Bayesian analysis of birthweight and censored gestational age using finite mixture models.

Authors:  Scott L Schwartz; Alan E Gelfand; Marie L Miranda
Journal:  Stat Med       Date:  2010-07-20       Impact factor: 2.373

5.  Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.

Authors:  Maria Makrides; Robert A Gibson; Andrew J McPhee; Lisa Yelland; Julie Quinlivan; Philip Ryan
Journal:  JAMA       Date:  2010-10-20       Impact factor: 56.272

6.  DHA supplementation and pregnancy outcomes.

Authors:  Susan E Carlson; John Colombo; Byron J Gajewski; Kathleen M Gustafson; David Mundy; John Yeast; Michael K Georgieff; Lisa A Markley; Elizabeth H Kerling; D Jill Shaddy
Journal:  Am J Clin Nutr       Date:  2013-02-20       Impact factor: 7.045

7.  Commensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials.

Authors:  Byron J Gajewski; C Shane Reese; John Colombo; Susan E Carlson
Journal:  Stat Biopharm Res       Date:  2016-06-02       Impact factor: 1.452

8.  Cost of hospitalization for preterm and low birth weight infants in the United States.

Authors:  Rebecca B Russell; Nancy S Green; Claudia A Steiner; Susan Meikle; Jennifer L Howse; Karalee Poschman; Todd Dias; Lisa Potetz; Michael J Davidoff; Karla Damus; Joann R Petrini
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

9.  Dichotomisation using a distributional approach when the outcome is skewed.

Authors:  Odile Sauzet; Mercy Ofuya; Janet L Peacock
Journal:  BMC Med Res Methodol       Date:  2015-04-24       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.